1. Executive Summary
1.1. Global Biofilm Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Biofilm Treatment Market Outlook, 2018 - 2030
3.1. Global Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Gauze
3.1.1.2. Dressing
3.1.1.3. Ointment
3.1.1.4. Gel
3.1.1.5. Others
3.2. Global Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Diabetic Foot Ulcer
3.2.1.2. Traumatic and Surgical Wounds
3.2.1.3. Pressure Ulcers
3.2.1.4. Venous Leg Ulcers
3.2.1.5. Burns and Other Open Wounds
3.3. Global Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Hospital
3.3.1.2. Ambulatory Surgical Centres
3.3.1.3. Wound Care Centres
3.3.1.4. Others
3.4. Global Biofilm Treatment Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Biofilm Treatment Market Outlook, 2018 - 2030
4.1. North America Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Gauze
4.1.1.2. Dressing
4.1.1.3. Ointment
4.1.1.4. Gel
4.1.1.5. Others
4.2. North America Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Diabetic Foot Ulcer
4.2.1.2. Traumatic and Surgical Wounds
4.2.1.3. Pressure Ulcers
4.2.1.4. Venous Leg Ulcers
4.2.1.5. Burns and Other Open Wounds
4.3. North America Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Hospital
4.3.1.2. Ambulatory Surgical Centres
4.3.1.3. Wound Care Centres
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.2. U.S. Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
4.4.1.3. U.S. Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
4.4.1.4. U.S. Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
4.4.1.5. Canada Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.6. Canada Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
4.4.1.7. Canada Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
4.4.1.8. Canada Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Biofilm Treatment Market Outlook, 2018 - 2030
5.1. Europe Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Gauze
5.1.1.2. Dressing
5.1.1.3. Ointment
5.1.1.4. Gel
5.1.1.5. Others
5.2. Europe Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Diabetic Foot Ulcer
5.2.1.2. Traumatic and Surgical Wounds
5.2.1.3. Pressure Ulcers
5.2.1.4. Venous Leg Ulcers
5.2.1.5. Burns and Other Open Wounds
5.3. Europe Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Hospital
5.3.1.2. Ambulatory Surgical Centres
5.3.1.3. Wound Care Centres
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.2. Germany Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.3. Germany Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.4. Germany Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.5. U.K. Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.6. U.K. Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.7. U.K. Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.8. U.K. Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.9. France Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.10. France Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.11. France Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.12. France Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.13. Italy Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.14. Italy Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.15. Italy Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.16. Italy Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.17. Turkey Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.18. Turkey Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.19. Turkey Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.20. Turkey Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.21. Russia Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.22. Russia Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.23. Russia Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.24. Russia Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.25. Rest of Europe Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.26. Rest of Europe Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.27. Rest of Europe Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.28. Rest of Europe Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biofilm Treatment Market Outlook, 2018 - 2030
6.1. Asia Pacific Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Gauze
6.1.1.2. Dressing
6.1.1.3. Ointment
6.1.1.4. Gel
6.1.1.5. Others
6.2. Asia Pacific Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Diabetic Foot Ulcer
6.2.1.2. Traumatic and Surgical Wounds
6.2.1.3. Pressure Ulcers
6.2.1.4. Venous Leg Ulcers
6.2.1.5. Burns and Other Open Wounds
6.3. Asia Pacific Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Hospital
6.3.1.2. Ambulatory Surgical Centres
6.3.1.3. Wound Care Centres
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.2. China Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.3. China Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.4. China Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.5. Japan Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.6. Japan Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.7. Japan Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.8. Japan Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.9. South Korea Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.10. South Korea Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.11. South Korea Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.12. South Korea Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.13. India Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.14. India Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.15. India Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.16. India Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.17. Southeast Asia Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.18. Southeast Asia Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.19. Southeast Asia Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.20. Southeast Asia Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.21. Rest of Asia Pacific Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.22. Rest of Asia Pacific Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.23. Rest of Asia Pacific Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.24. Rest of Asia Pacific Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biofilm Treatment Market Outlook, 2018 - 2030
7.1. Latin America Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Gauze
7.1.1.2. Dressing
7.1.1.3. Ointment
7.1.1.4. Gel
7.1.1.5. Others
7.2. Latin America Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Diabetic Foot Ulcer
7.2.1.2. Traumatic and Surgical Wounds
7.2.1.3. Pressure Ulcers
7.2.1.4. Venous Leg Ulcers
7.2.1.5. Burns and Other Open Wounds
7.3. Latin America Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Hospital
7.3.1.2. Ambulatory Surgical Centres
7.3.1.3. Wound Care Centres
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.2. Brazil Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.3. Brazil Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.4. Brazil Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.5. Mexico Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.6. Mexico Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.7. Mexico Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.8. Mexico Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.9. Argentina Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.10. Argentina Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.11. Argentina Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.12. Argentina Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.13. Rest of Latin America Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.14. Rest of Latin America Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.15. Rest of Latin America Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.16. Rest of Latin America Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biofilm Treatment Market Outlook, 2018 - 2030
8.1. Middle East & Africa Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Gauze
8.1.1.2. Dressing
8.1.1.3. Ointment
8.1.1.4. Gel
8.1.1.5. Others
8.2. Middle East & Africa Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Diabetic Foot Ulcer
8.2.1.2. Traumatic and Surgical Wounds
8.2.1.3. Pressure Ulcers
8.2.1.4. Venous Leg Ulcers
8.2.1.5. Burns and Other Open Wounds
8.3. Middle East & Africa Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Hospital
8.3.1.2. Ambulatory Surgical Centres
8.3.1.3. Wound Care Centres
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.2. GCC Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.3. GCC Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.4. GCC Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.5. South Africa Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.6. South Africa Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.7. South Africa Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.8. South Africa Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.9. Egypt Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.10. Egypt Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.11. Egypt Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.12. Egypt Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.13. Nigeria Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.14. Nigeria Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.15. Nigeria Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.16. Nigeria Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.17. Rest of Middle East & Africa Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.18. Rest of Middle East & Africa Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.19. Rest of Middle East & Africa Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.20. Rest of Middle East & Africa Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. End User vs Application Heatmap
9.2. Manufacturer vs Application Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. BluePrint Wound
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Novozymes A/S
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. 3M Company
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Pfizer Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Merck & Co. Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Sanofi
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Biofilm Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. ConvaTec Group PLC
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Abbott Laboratories
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. BioGaia AB
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Kane Biotech Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Others
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations